COSCIENS Biopharma Inc. (CSCI) — Free Cash Flow Generation Index
COSCIENS Biopharma Inc. (CSCI) has a Free Cash Flow Generation Index of 0.65x as of September 2023. Free cash flow of $94.00K represents 1% of operating cash flow ($144.00K). Read CSCI total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
COSCIENS Biopharma Inc. Free Cash Flow Generation Index (2003–2022)
Historical FCF Generation Index trend for COSCIENS Biopharma Inc. across 13 annual periods. Explore CSCI capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for COSCIENS Biopharma Inc. (2003–2022)
Year-by-year Free Cash Flow Generation Index for COSCIENS Biopharma Inc.. For the full company profile including market capitalisation, see COSCIENS Biopharma Inc. (CSCI) market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.94x | $4.92 Million | $5.23 Million | $10.57K | ▲ +18.0% |
| 2021 | 0.80x | $2.20 Million | $2.75 Million | $555.99K | ▼ -7.3% |
| 2020 | 0.86x | $3.01 Million | $3.49 Million | $485.46K | ▲ +39.6% |
| 2019 | 0.62x | $416.39K | $675.29K | $3.49 | ▲ +139.7% |
| 2017 | -1.55x | $-1.94 Million | $1.25 Million | $3.20 Million | ▼ -7809.0% |
| 2016 | -0.02x | $-71.44K | $3.63 Million | $3.71 Million | ▲ +65.0% |
| 2015 | -0.06x | $-161.00K | $2.87 Million | $3.03 Million | ▲ +95.2% |
| 2014 | -1.16x | $-2.14 Million | $1.84 Million | $3.98 Million | ▲ +68.5% |
| 2013 | -3.70x | $-1.70 Million | $460.21K | $2.16 Million | ▼ -538.3% |
| 2011 | 0.84x | $668.32K | $791.62K | $123.30K | ▲ +4.2% |
| 2010 | 0.81x | $388.42K | $479.50K | $85.01K | ▲ +54.2% |
| 2006 | 0.53x | $73.86K | $140.59K | $66.73K | ▲ +158.8% |
| 2003 | -0.89x | $-48.63K | $54.42K | $103.05K | — |